IDegLira for type 2 diabetes: a systematic review and meta-analysis
Article in Endocrine (September 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients
Article in Diabetology & Metabolic Syndrome (August 2023)
A Relative Cost of Control Analysis of IDegLira versus Other Forms of Basal Insulin Intensification in Mexico
Article in PharmacoEconomics - Open (July 2023)